A multidisciplinary team of researchers from the Hospital Clínic Barcelona-IDIBAPS-UB, coordinated by Carolina García-Vidal and Pedro Puerta of the H1
Service News from Microbiology
Rapid reporting of the results of a microbiological examination for an infection is as important as having rapid diagnostic technologies to detect it.
The US Food and Drug Administration (FDA) has approved the first faecal microbiota-derived product for the treatment of infection with Clostridioides1
Intestinal microbiota performs essential functions in our body but can sometimes be damaged by taking antibiotics, or certain treatments such as chem1